FDA Inspection
Grifols Diagnostic Solutions Inc.Grifols Diagnostic Solutions Inc. – FDA Inspection, Jan 18, 2016
Record Details
This FDA Inspection record concerns Grifols Diagnostic Solutions Inc., with an inspection on January 18, 2016, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- January 18, 2016
- Product Type
- Biologics
View Company Profile
ID · fb100bc2-1500-4789-b450-0789b70e75e3
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 960885
- FDA center
- Biologics
- Project area
- Blood and Blood Products
Other FDA inspections of Grifols Diagnostic Solutions Inc.
13| Date | Classification | Office | Project area |
|---|---|---|---|
| August 26, 2025 | VAI | Los Angeles District Office | Blood and Blood Products |
| June 28, 2024 | Not classified | Los Angeles District Office | |
| April 3, 2023 | Not classified | Los Angeles District Office | |
| February 17, 2022 | NAI | Center for Biologics Evaluation and Research | Vaccines and Allergenic Products |
| December 10, 2018 | NAI | Center for Devices and Radiological Health | Bioresearch Monitoring |
Other documents for Grifols Diagnostic Solutions Inc.
- FDA Inspection 1279554 - 2025-08-26
- FDA Inspection 1243819 - 2024-06-28
- FDA Inspection 1204974 - 2023-04-03
- FDA Inspection 1162488 - 2022-02-17
- FDA Inspection 1076855 - 2018-12-10
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.